Physician profile
Patrick Wood
NPI 1528086915
$1,243.19
in general payments reported to CMS, 2019-2025
13 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $282 · 2022: $17.85 · 2023: $120 · 2024: $459 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $287.39 | 2020-2024 | Jardiance, Mounjaro |
| Novo Nordisk INC | $226.66 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $137.59 | 2020 | |
| Pfizer INC. | $116.92 | 2023-2025 | |
| Baxter Healthcare | $114.09 | 2020 | |
| Verona Pharma, INC. | $93.20 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.21 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $59.87 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $45.85 | 2025 | Airsupra, Breztri |
| Vertex Pharmaceuticals Incorporated | $23.00 | 2025 | |
| Alnylam Pharmaceuticals INC. | $18.66 | 2024 | Oxlumo |
| Glaxosmithkline, LLC. | $15.19 | 2020 | |
| Viatris Specialty LLC | $14.56 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.